Search company, investor...

Predict your next investment

Venture Capital
biomedicine.ch

Investments

2

Portfolio Exits

1

Funds

1

About Biomedicine

International BM Biomedicine Holdings is an investment firm which invests in leading technology-based, research-oriented biotechnology companies in the pharmaceutical area. The firm uses Global Biomedical Partners as its exclusive investment advisor to perform due diligence and make recommendations that IBMH acts on.

Headquarters Location

Nauenstrasse 41

Basel, 4002,

Switzerland

41 61 270 8210

Want to inform investors similar to Biomedicine about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Biomedicine News

Bio Pharmaceuticals And Biomedicine Market Growth in Future Scope 2023-2030-Report by Coherent Market Insights

Mar 10, 2023

News Provided By Share This Article Bio Pharmaceuticals And Biomedicine Market Trend Bio Pharmaceuticals And Biomedicine Market Size to Reach US$ 1,165,862.8 Million, With a CAGR of 9.6% by 2030 BURLINGAME, CALIFORNIA, UNITED STATES, March 9, 2023 / EINPresswire.com / -- Coherent Market Insights has published a latest research study “Biopharmaceutical and Biomedicine Market” 2023 analysis by the following subjects: Industry size, share, growth, segmentation, companies and developments, key trends, market drivers, restraints, regulations, opportunities, strategies, potential road maps and annual forecast till 2030. Your business will grow much faster with the help of an authentic source of statistical surveying from the Biopharmaceutical and Biomedicine Market Report. This Report also explores critical data such as expenditure, costs, revenue, and end-clients. A biopharmaceutical (biological or biologic), which consists of sugars, proteins, nucleic acids, living cells, or tissues, is a medicinal product semi-synthesized from biological sources such as humans, animals, or microorganisms. Biopharmaceuticals has emerged as one of the key segments with immense growth potential in the healthcare sector Request For Premium Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/18 The purpose of the report is to offer a comprehensive analysis of the market, along with insightful conclusions, statistical data, historical information, market data that has been confirmed by the industry, and predictions based on a sound methodology. By identifying and examining market segments and forecasting global market size, the study also contributes to understanding the dynamics and structure of the global Biopharmaceutical and Biomedicine market. This report also investigates the competitive positioning of key companies in terms of product, pricing, financial situation, product portfolio, growth strategies, and geographical presence. The Major players profiled in this report include: Amgen Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi, Eli Lilly and Company, AbbVie Inc., Novo Nordisk A/S, Bristol-Myers Squibb Company, NanoString, QIAGEN, Affimed GmbH, GSK plc., Merck KgaA, and Teva Pharmaceutical Industries Ltd. Biopharmaceutical and Biomedicine Market Scope and Market Size The Biopharmaceutical and Biomedicine market is segmented on the basis of product, customer, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with a valuable market overview and market insights to help them in making strategic decisions for the identification of core market applications. The global Biopharmaceutical and Biomedicine market is segmented on the basis of application, type, distribution channel, and geography. Market Segmentation: By Product Type: Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Human Insulin, Human Growth Hormone, Erythropoietin, Interferon, Colony Stimulating Factor, Blood Factors, Fusion Protein, Others), Nanomedicine, Cell & Gene Therapy, Bioinformatics, Molecular Enzymes & Kits By Application: Therapeutics, Diagnostics, Research and Development Purchasing This Business Report (𝐆𝐞𝐭 𝐔𝐩 𝐭𝐨 𝟒𝟓% 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭 ): https://www.coherentmarketinsights.com/promo/buynow/18 Regional Analysis for Biopharmaceutical and Biomedicine Market: 🡆 North America: U.S. and Canada 🡆 Latin America: Brazil, Argentina, Mexico, and Rest of Latin America 🡆 Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe 🡆 Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific 🡆 Middle East: GCC Countries, Israel, and Rest of Middle East 🡆 Africa: South Africa, North Africa, and Central Africa The report provides insights on the following pointers: ⏩ Market Penetration: Comprehensive information on the product portfolios of the top players in the Biopharmaceutical and Biomedicine market. ⏩ Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the market. ⏩ Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market. ⏩ Market Development: Comprehensive information about emerging markets. This report analyses the market for various segments across geographies. ⏩ Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Biopharmaceutical and Biomedicine market. Benefits of the Report: ⏩ A descriptive analysis of demand-supply gap, estimation, SWOT analysis and forecast in the global market. ⏩ Porter’s five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players. ⏩ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market ⏩ Top- down and bottom-up approach for regional analysis Purchase this report now @ https://www.coherentmarketinsights.com/promo/buynow/18 Frequently Asked Questions ✔ What will be the progress rate of the Biopharmaceutical and Biomedicine Market for the conjecture period 2030? ✔ What are the prominent factors driving the Biopharmaceutical and Biomedicine Market across different regions? ✔ Who are the major vendors dominating the Biopharmaceutical and Biomedicine industry and what are their winning strategies? ✔ What will be the market scope for the estimated period? Other Trending Reports: Bacteriophage Therapy Market - https://www.coherentmarketinsights.com/market-insight/bacteriophages-therapy-market-2752 About Us: Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients. Mr. Shah +1 206-701-6702

Biomedicine Investments

2 Investments

Biomedicine has made 2 investments. Their latest investment was in Artemis Pharmaceuticals as part of their Series B on April 4, 2000.

CBI Logo

Biomedicine Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/5/2000

Series B

Artemis Pharmaceuticals

$12.56M

No

1

9/16/1998

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/5/2000

9/16/1998

Round

Series B

Series A

Company

Artemis Pharmaceuticals

Subscribe to see more

Amount

$12.56M

$99M

New?

No

Subscribe to see more

Co-Investors

Sources

1

10

Biomedicine Portfolio Exits

1 Portfolio Exit

Biomedicine has 1 portfolio exit. Their latest portfolio exit was Artemis Pharmaceuticals on April 01, 2001.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/1/2001

Acquired

$99M

Undisclosed Investors

Date

4/1/2001

Exit

Acquired

Companies

Valuation

$99M

Acquirer

Undisclosed Investors

Sources

Biomedicine Fund History

1 Fund History

Biomedicine has 1 fund, including Biomedicine LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

1/1/2000

Biomedicine LP

Buyouts & Acquisitions

Closed

$73.53M

1

Closing Date

1/1/2000

Fund

Biomedicine LP

Fund Type

Buyouts & Acquisitions

Status

Closed

Amount

$73.53M

Sources

1

Biomedicine Team

4 Team Members

Biomedicine has 4 team members, including current Chief Executive Officer, Patrick Weber.

Name

Work History

Title

Status

Patrick Weber

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Patrick Weber

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.